Evaluation of very high-and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degeneration

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 6, 2012, Pages 581-588

  Nguyen, Quan Dong ^a   Campochiaro, Peter A ^a   Shah, Syed Mahmood ^a   Browning, David J ^b   Hudson, Henry L ^c   Sonkin, Peter L ^d   Hariprasad, Seenu M ^e   Kaiser, Peter K ^f   Slakter, Jason ^g   Haller, Julia A ^a   Do, Diana V ^a   Mieler, William ^e   Chu, Karen ^h   Ingerman, Avner ^h   Vitti, Robert ^h   Berliner, Alyson J ^h   Cedarbaum, Jesse ^h  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Charlotte Eye Ear Nose and Throat Associates PA ^*  (United States)

^c Retina Centers PC   (United States)

^d Tennessee Retina PC   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^h REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT;

ADULT; AGED; ANTERIOR EYE CHAMBER DISEASE; ARTICLE; CATARACT; CLINICAL ARTICLE; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; EYE INFLAMMATION; FEMALE; HUMAN; HYPEREMIA; INTRAOCULAR PRESSURE; LOW DRUG DOSE; MALE; OCULAR HYPEREMIA; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REFRACTION ERROR; RETINA MACULA AGE RELATED DEGENERATION; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ACUITY; VITRITIS;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOVEA CENTRALIS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84869401366     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0261     Document Type: Article

References (11)

1. Okamoto, N., Tobe, T., Hackett, S.F., et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am. J. Pathol. 151:281- 291, 1997.
2. Kwak, N., Okamoto, N., Wood, J.M., and Campochiaro, P.A. VEGF is major stimulator in model of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 41:3158-3164, 2000.
3. Saishin, Y., Saishin, Y., Takahashi, K., et al. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J. Cel.l Physiol. 195:241- 248, 2003. (Pubitemid 36384298)
4. Krzystolik, M.G., Afshari, M.A., Adamis, A.P., et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol. 120:338-346, 2002. (Pubitemid 34250056)
5. Rosenfeld, P.J., Brown, D.M., Heier, J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355:1419-1431, 2006. (Pubitemid 44511557)
6. Brown, D.M., Kaiser, P.K., Michels, M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 355:1432-1444, 2006. (Pubitemid 44511558)
7. Holash, J., Davis, S., Papadopoulos, N., et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc. Natl. Acad. Sci. U. S. A. 99:11393-11398, 2002. (Pubitemid 34920936)
8. Nguyen, Q.D., Shah, S.M., Hafiz, G., et al. A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related y. Ophthalmology 113:1522 e1521-1522 e1514, 2006.
9. Stewart, M.W., and Rosenfeld, P.J. Predicted biological activity of intravitreal VEGF Trap. Br. J. Ophthalmol. 92:667- 668, 2008. (Pubitemid 351684178)
10. Nguyen, Q.D., Shah, S.M., Browning, D.J., et al. A phase I study of intravitreal vascular endothelial growth factor trapeye in patients with neovascular age-related macular degeneration. Ophthalmology 116:2141-2148 e2141, 2009.
11. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol. 109:1220-1231, 1991.